Vaxfab Enterp.

Why is Vaxfab Enterprises Ltd falling/rising?

As of 19-Jun, Vaxfab Enterprises Ltd's stock price is declining slightly at 61.06, despite strong long-term gains. Recent underperformance against the Sensex and reduced investor participation are contributing to this decrease.

As of 19-Jun, Vaxfab Enterprises Ltd is experiencing a slight decline in its stock price, currently at 61.06, which reflects a change of -0.15 or -0.25%. This decrease is occurring despite the stock's strong performance over longer periods, such as a 62.26% increase year-to-date and a remarkable 307.07% rise over the past year. However, in the short term, the stock has underperformed against the benchmark Sensex, which has risen by 1.69% over the past week, while Vaxfab's stock has decreased by 0.16%.<BR><BR>Additionally, today's performance indicates that Vaxfab has underperformed its sector by 0.52%. The stock's moving averages show that it is higher than the 20-day, 50-day, 100-day, and 200-day averages, but lower than the 5-day moving average, suggesting some recent volatility. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 50.79% compared to the 5-day average, indicating reduced trading interest. <BR><BR>Overall, the combination of recent underperformance relative to the sector and a decline in investor participation are contributing factors to the current decrease in Vaxfab Enterprises Ltd's stock price.

Which are the latest news on Vaxfab Enterp.?

What does Vaxfab Enterp. do?

Vaxfab Enterprises Ltd, a Micro Cap company incorporated in 1983, trades in fabrics and garments. As of March 2026, it reported net sales of 9 Cr and a net profit of 3 Cr, with a market cap of INR 160 Cr.

Overview:<BR>Vaxfab Enterprises Ltd is engaged in the trading of fabrics and garments within the Trading & Distributors industry, classified as a Micro Cap company.<BR><BR>History:<BR>Vaxfab Enterprises Ltd was incorporated on 9th February 1983, originally under the name Ellora Trading Limited. The company underwent a name change to Vaxfab Enterprises Limited on 16th July 2022. The latest reported quarterly results indicate net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 9 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 3 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 160 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 141.00<BR>- Industry P/E: 21<BR>- Dividend Yield: 0.00%<BR>- Debt-Equity: 0.95<BR>- Return on Equity: -10.60%<BR>- Price to Book: 3.46<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

How big is Vaxfab Enterp.?

As of 10th June, Vaxfab Enterprises Ltd has a market capitalization of 160.00 Cr, with net sales of 120.62 Cr and a net profit of 1.15 Cr reported in the latest four quarters. Shareholder's funds are 16.47 Cr, and total assets amount to 26.58 Cr as of March 2023.

As of 10th June, Vaxfab Enterprises Ltd has a market capitalization of 160.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Vaxfab Enterprises Ltd reported net sales of 120.62 Cr and a net profit of 1.15 Cr.<BR><BR>The latest annual period for the balance sheet is March 2023, with shareholder's funds amounting to 16.47 Cr and total assets of 26.58 Cr.

Who are in the management team of Vaxfab Enterp.?

The management team of Vaxfab Enterprises includes Komal Jain (Company Secretary), Devi Singh (Managing Director), Premaram Patel (Independent Director), Kailash Gupta (Non-Executive Director), and Chinu Kalal (Independent Director).

The management team of Vaxfab Enterprises includes the following individuals:<BR><BR>1. **Komal Jain** - Company Secretary<BR>2. **Devi Singh** - Managing Director<BR>3. **Premaram Patel** - Independent Director<BR>4. **Kailash Gupta** - Non-Executive Director<BR>5. **Chinu Kalal** - Independent Director<BR><BR>If you need more details about their roles or the company, feel free to ask!

Who are the peers of the Vaxfab Enterp.?

Vaxfab Enterp.'s peers include East India Drums, Metroglobal, Chemkart India, Maximus Interna., Signet Industrie, Rama Vision, Dhoot Indl.Fin, and Lahoti Overseas. Vaxfab Enterp. has the highest 1-year return at 320.07%, significantly outperforming its peers.

Peers: The peers of Vaxfab Enterp. are East India Drums, Metroglobal, Chemkart India, Maximus Interna., Signet Industrie, Rama Vision, Dhoot Indl.Fin, and Lahoti Overseas.<BR><BR>Quality Snapshot: Below Average management risk is observed at East India Drums, Vaxfab Enterp., and Lahoti Overseas, while Average management risk is found at Maximus Interna., Signet Industrie, Rama Vision, Dhoot Indl.Fin, and the rest. Good management risk is present at Chemkart India, while Average growth is noted at Vaxfab Enterp., Metroglobal, Maximus Interna., Signet Industrie, Dhoot Indl.Fin, and the rest. Excellent growth is seen at East India Drums and Good growth at Rama Vision, while Below Average growth is found at Chemkart India and Lahoti Overseas. Below Average capital structure is noted at East India Drums, Vaxfab Enterp., Signet Industrie, Dhoot Indl.Fin, and the rest, while Excellent capital structure is observed at Metroglobal, Chemkart India, and Lahoti Overseas.<BR><BR>Return Snapshot: Vaxfab Enterp. has the highest 1-year return at 320.07%, while Chemkart India has the lowest return, which is N/A. Vaxfab Enterp.'s return significantly exceeds that of its peers. Additionally, the six-month returns for Chemkart India, Signet Industrie, and Rama Vision are negative.

Should I buy, sell or hold Vaxfab Enterprises Ltd?

Are Vaxfab Enterprises Ltd latest results good or bad?

Vaxfab Enterprises Ltd's latest Q3 FY26 results are concerning, showing a net loss of ₹3.24 crores compared to a profit of ₹6.41 crores last year, alongside a 71.55% revenue decline. The company's financial performance indicates significant challenges and volatility, warranting caution from investors.

Vaxfab Enterprises Ltd's latest results for Q3 FY26 are concerning. The company reported a net loss of ₹3.24 crores, a significant decline compared to a net profit of ₹6.41 crores in the same quarter last year. This marks a dramatic reversal in performance, reflecting operational challenges and a sharp decline in revenue, which fell by 71.55% quarter-on-quarter to ₹15.66 crores.<BR><BR>The operating margin also collapsed to just 2.04%, down from 13.92% a year ago, indicating severe margin compression. Additionally, the company faced an extraordinary negative other income charge of ₹3.37 crores, which has raised questions about the sustainability of its business model.<BR><BR>While Vaxfab's return on equity (ROE) remains strong at 55.06%, the overall financial performance shows significant volatility and deterioration. The company's Mojo Score of 54/100 and a HOLD rating suggest that investors should exercise caution. Given these results, the outlook appears challenging, and the company faces substantial headwinds moving forward.

When is the next results date for Vaxfab Enterprises Ltd?

The next results date for Vaxfab Enterprises Ltd is 30 May 2026.

The next results date for Vaxfab Enterprises Ltd is scheduled for 30 May 2026.

Is Vaxfab Enterp. overvalued or undervalued?

As of November 17, 2025, Vaxfab Enterprises is considered undervalued with a PE ratio of 4.69, an EV to EBIT of 3.44, a ROCE of 61.79%, and a PEG ratio of 0.02, significantly outperforming peers and the Sensex, with a year-to-date return of 247.66%.

As of 17 November 2025, Vaxfab Enterprises has moved from a fair to a very attractive valuation grade. The company is currently considered undervalued, supported by a PE ratio of 4.69, an EV to EBIT of 3.44, and a remarkable ROCE of 61.79%. In comparison to peers, Vaxfab's valuation metrics stand out significantly; for instance, Elitecon International has a PE ratio of 294.38, while PTC India, another attractive peer, has a PE ratio of 7.56.<BR><BR>The company's strong performance is further underscored by its PEG ratio of 0.02, indicating substantial growth potential relative to its price. Despite a recent dip in stock price, Vaxfab has demonstrated impressive returns year-to-date at 247.66%, significantly outperforming the Sensex's 8.72% during the same period. Overall, the compelling valuation ratios and robust performance metrics suggest that Vaxfab Enterprises is indeed undervalued in the current market.

How has been the historical performance of Vaxfab Enterp.?

Vaxfab Enterp. experienced significant growth from March 2022 to March 2023, with net sales rising to 16.75 Cr from 0.27 Cr, and a profit after tax of 0.33 Cr compared to 0.00 Cr the previous year. Total assets increased to 26.58 Cr from 3.15 Cr, indicating a strong financial improvement.

Answer:<BR>The historical performance of Vaxfab Enterp. shows significant growth from March 2022 to March 2023.<BR><BR>Breakdown:<BR>In March 2023, Vaxfab Enterp. reported net sales of 16.75 Cr, a substantial increase from 0.27 Cr in March 2022. Total operating income also rose to 16.75 Cr from 0.27 Cr, while total expenditure increased to 16.29 Cr from 0.36 Cr. The operating profit (PBDIT) improved to 0.46 Cr from a loss of 0.09 Cr, resulting in a profit before tax of 0.45 Cr compared to no profit in the previous year. Consequently, the profit after tax reached 0.33 Cr, up from 0.00 Cr. The consolidated net profit for March 2023 was 0.39 Cr, reflecting a notable improvement from the previous year's figure of 0.00 Cr. The company's equity capital increased to 8.40 Cr from 1.20 Cr, and total assets grew to 26.58 Cr from 3.15 Cr. Additionally, cash flow from operating activities was 1.00 Cr, with a net cash inflow of 4.00 Cr, indicating a positive cash position compared to the previous year.

Who are the top shareholders of the Vaxfab Enterp.?

The top shareholders of Vaxfab Enterprises are primarily individual investors, holding 81.84% of the shares, with Varsha Vaibhav Patil as the largest public shareholder at 8.45%. There are no institutional investors or pledged promoter holdings.

The top shareholders of Vaxfab Enterprises include individual investors, who hold a significant 81.84% of the company's shares. Among public shareholders, Varsha Vaibhav Patil stands out with a holding of 8.45%. There are no institutional investors or mutual funds currently holding shares in the company, and there are no pledged promoter holdings.

What is the technical trend for Vaxfab Enterp.?

As of May 16, 2025, Vaxfab Enterprises shows a strong bullish trend supported by positive MACD, Bollinger Bands, and moving averages across weekly and monthly time frames.

As of 16 May 2025, the technical trend for Vaxfab Enterp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a strong upward momentum. Bollinger Bands also indicate a bullish stance on both time frames. The daily moving averages confirm a bullish trend as well. The KST is bullish on the weekly and mildly bullish on the monthly, while Dow Theory shows a mildly bullish outlook in both time frames. Overall, the current technical stance is bullish with strong indicators supporting this trend.

Has Vaxfab Enterp. declared dividend?

No Dividend History Available